RIPK4 was significantly suppressed in 80% of the hepatocellular carcinoma (HCC) samples, and RIPK4 overexpression resulted in almost complete elimination of anchorage-independent growth in the already transformed human fetal hepatocytes. Here, RIPK4 is linked to hepatocellular carcinoma.